The orbit

Ophthalmology Clinics of North America

Volumn 14, Issue 1, 2001, Pages 109-127

  Phillips, P H ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; FLUCYTOSINE; ITRACONAZOLE;

ADULT; AGED; ASPERGILLOSIS; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EXOPHTHALMOS; FEMALE; GRAVES DISEASE; HUMAN; MALE; MENINGIOMA; MUCORMYCOSIS; OPTIC NERVE DISEASE; OPTIC NERVE GLIOMA; ORBIT DISEASE; ORBIT PSEUDOTUMOR; PRIORITY JOURNAL; REVIEW;

ASPERGILLOSIS; EYE INFECTIONS, FUNGAL; GRAVES DISEASE; HUMANS; MUCORMYCOSIS; OPTIC NERVE NEOPLASMS; ORBIT; ORBITAL DISEASES; VISUAL PATHWAYS;

EID: 0035027759     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Dysthyroid optic neuropathy without extraocular muscle involvement
2. Fungi and mycotic diseases
3. Pathogenesis of Graves' ophthalmopathy
4. Autoimmune endocrine disease
5. Painless orbital apex syndrome from mucormycosis
6. Optic nerve dysfunction in thyroid eye disease: CT
7. Cigarette smoking and treatment outcomes in Graves ophthalmopathy
8. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy
9. The chronology of Graves' ophthalmopathy in an incidence cohort
10. Clinical features of Graves' ophthalmopathy in an incidence cohort
11. The incidence of Graves' ophthalmopathy in Olmsted county, Minnesota
12. Diagnostic criteria for Graves' ophthalmopathy
13. Rhino-orbital mucormycosis occurring in an otherwise apparently healthy individual
14. Place of radiotherapy in the treatment of Graves' orbitopathy
15. Low-dose cyclosporine therapy of granulomatous optic neuropathy and orbitopathy
16. Clinical signs of orbital ischemia in rhino-orbitocerebral mucormycosis
17. Optimization of stationary and moving beam radiation therapy techniques
18. Long-term efficacy of orbital decompression for compressive optic neuropathy of Graves' eye disease
19. Tumors of the meninges and related tissues: Meningiomas and sarcomas
20. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2
21. Idiopathic inflammatory orbital pseudotumor and low-dose cyclosporine
22. Sudden blindness and total ophthalmoplegia in mucormycosis: A clinicopathological correlation
23. Gliomas of the anterior visual pathway
24. Optic nerve sheath meningiomas
25. Precision radiation therapy for optic nerve sheath meningiomas
26. Diagnosis and management of rhinoorbitocerebral mucormycosis (phycomycosis): A report of 16 personally observed cases
27. A new approach to an old problem
28. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy
29. Orbital decompression for preservation of vision in Graves' ophthalmopathy
30. Optic neuropathy of Graves' disease: Treatment by transantral or transfrontal orbital decompression
31. Tumors of neuroectodermal origin
32. Graves exophthalmos unrelated to extraocular muscle enlargement: Superior rectus muscle inflammation may induce venous obstruction
33. An individualized approach to orbital decompression in Graves' orbitopathy
34. Gliomas of the anterior visual pathways
35. Combined clinical and computed tomographic diagnosis of orbital glioma and meningioma
36. Optic glioma in children: Surveillance, or irradiation?
37. Sino-orbital aspergillosis in acquired immunodeficiency syndrome
38. Radiotherapy in the management of thyroid orbitopathy: Computed tomography and clinical outcomes
39. Intracranial extension of inflammatory pseudotumor of the orbit
40. Treatment of acute graves orbitopathy
41. Is Graves ophthalmopathy a preventable disease?
42. Graves ophthalmopathy
43. Intravenous methylprednisone in the treatment of Graves' ophthalmopathy
44. Endoscopic transnasal orbital decompression
45. Discussion: Outcome of orbital myositis: Clinical features associated with recurrence
46. The management of sclerosing nonspecific orbital inflammation
47. The management of optic nerve sheath meningiomas
48. Management of limited rhinoorbital mucormycosis without exenteration
49. Infiltrative optic neuropathies
50. Irradiation of meningiomas of the intracranial anterior visual pathway
51. A practice pathway for the management of gliomas of the anterior visual pathway: An update and an evidence-based approach
52. Improvement in visual function in an eye with presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy
53. Treatment protocol for orbital inflammatory disease
54. The spectrum of orbital aspergillosis: A clinicopathological review
55. Optic nerve sheath meningioma: Definition of intraorbital, intracanalicular, and intracranial components with magnetic resonance imaging
56. Optic gliomas in children with neurofibromatosis type 1
57. Spontaneous visual improvement in chiasmal gliomas
58. Orbital decompression for thyroid eye disease: A comparison of external and endoscopic techniques
59. Outcome of orbital myositis: Clinical features associated with recurrence
60. Has the target autoantigen for Graves' ophthalmology been found?
61. Iron overload is a risk factor for zygomycosis
62. Endoscopic orbital decompression
63. What is orbital pseudotumor?
64. Current status in the treatment of orbital myositis
65. Graves orbitopathy: Correlation of CT and clinical findings
66. Efficacy of chemotherapy for children with newly diagnosed progressive low-grade gliomas
67. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood
68. Chiasmatic gliomas of childhood: A reappraisal of natural history and effectiveness of cranial irradiation
69. Treatment of Chiasmal/hypothalamic gliomas of childhood with chemotherapy: An update
70. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy
71. Rhinocerebral mucormycosis and internal carotid artery thrombosis in a previously healthy patient
72. Inflammatory diseases
73. Extreme eyelid swelling as an unusual presentation of dysthyroid orbitopathy
74. Optic nerve sheath meningioma: Diagnostic features and therapeutic alternatives
75. Thyroid eye disease
76. Optic nerve sheath meningiomas: Clinical manifestations
77. The association between cigarette smoking and ocular diseases
78. Presumed isolated inflammation of the superior oblique muscle in idiopathic orbital myositis
79. Dysthyroid optic neuropathy: Clinical profile and rationale for management
80. Recognition and differential diagnosis of enlarged extraocular muscles in computed tomography
81. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease
82. Orbital fat removal: Decompression for Graves orbitopathy
83. Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy
84. Long-term follow-up and recent observations on 305 cases of orbital decompression for dysthyroid orbitopathy
85. Sclerosing orbital pseudotumor: A unique clinicopathologic entity
86. Radiotherapy for thyroid orbitopathy: Effects on extraocular muscle balance
87. Primary optic nerve sheath meningioma
88. Survival factors in rhino-orbital-cerebral mucormycosis
89. Successfully treated spheno-orbital mucormycosis in an otherwise healthy adult